Sample Collection and General Screening Protocols
样品采集和一般筛选方案
基本信息
- 批准号:9562819
- 负责人:
- 金额:$ 180.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Biological AssayBiopsyBloodBlood Component RemovalBody FluidsCellsClinicalClinical TrialsCommunicable DiseasesDataDevelopmentDiagnostic radiologic examinationDiseaseEligibility DeterminationEmerging Communicable DiseasesHIVHumanImage AnalysisImmuneImmune responseImmunityImmunology procedureInvestigationLaboratoriesLaboratory ResearchMeasuresMedicineMethodsMonoclonal AntibodiesMononuclearPathogenesisPlasmaProceduresProtocols documentationResearchResearch PersonnelSamplingSeverity of illnessSkinSpecimenSwabTissuesTransfusionUnited States National Institutes of HealthVaccinatedVaccine Clinical TrialVaccinesValidationVenous blood samplingVirus DiseasesWorkexperiencehealthy volunteerimmune functionimmunogenicityresearch clinical testingresearch studysample collectionscreeningvaccine candidatevaccine developmentvolunteer
项目摘要
The purpose of this project is to screen volunteers for protocols that involve the administration of investigational agents and to collect human specimens, such as blood, mucosal secretions, skin swabs, skin biopsy, or body fluids, and in some circumstances perform radiographic imaging and clinical evaluations, to support laboratory research studies and to validate research assays used in evaluation of clinical trials immunogenicity results. These samples and data are used by laboratory researchers in their work on the development of vaccines and monoclonal antibodies targeting HIV and other emerging infectious diseases, to study the correlates of immunity related to infectious diseases, and in laboratory work related to the development and/or validation of immunological assays. In order to carry out research studies, it is sometimes necessary to obtain larger quantities of plasma or mononuclear cells than can be safely obtained by simple phlebotomy. These components can be safely obtained using apheresis procedures, which are performed in the NIH Clinical Center Department of Transfusion Medicine (DTM).
本项目的目的是筛选志愿者,以了解涉及研究药物给药的方案,并收集人体标本,如血液、粘膜分泌物、皮肤拭子、皮肤活检或体液,在某些情况下进行放射成像和临床评价,以支持实验室研究,并验证临床试验免疫原性结果评价中使用的研究测定。 这些样本和数据被实验室研究人员用于开发针对艾滋病毒和其他新兴传染病的疫苗和单克隆抗体,研究与传染病相关的免疫相关性,以及与开发和/或验证免疫测定相关的实验室工作。 为了进行研究,有时需要获得比通过简单静脉切开术安全获得的更大量的血浆或单核细胞。 这些成分可以使用在NIH临床中心输血医学部(DTM)进行的单采程序安全地获得。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julie E. Ledgerwood其他文献
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study
成人HIV-1预防性单克隆抗体固定剂量与基于体重给药的比较:一项事后、跨方案药代动力学建模研究
- DOI:
10.1016/j.ebiom.2025.105804 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:10.800
- 作者:
Yunda Huang;Lily Zhang;Huub Gelderblom;Kelly E. Seaton;Nicole L. Yates;Carmen A. Paez;Shelly T. Karuna;Philip Andrew;Theresa Gamble;Samuel T. Robinson;Julie E. Ledgerwood;Ollivier Hyrien;Stephen R. Walsh;Cynthia L. Gay;Jane A. Gwira;Hans M.L. Spiegel;Magdalena E. Sobieszczyk;Sharon B. Mannheimer;Srilatha Edupuganti;Christopher B. Hurt;Judy Stein - 通讯作者:
Judy Stein
VRC 311: Phase I Clinical Trial of a Virus-Like Particle Chikungunya Vaccine in Healthy Adults
- DOI:
10.1016/j.jaci.2012.12.1555 - 发表时间:
2013-02-01 - 期刊:
- 影响因子:
- 作者:
Lee-Jah Chang;Floreliz Mendoza;Jamie Saunders;Sarah Plummer;Galina V. Yamshchikov;Julie E. Ledgerwood;Barney S. Graham - 通讯作者:
Barney S. Graham
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
第 1 阶段剂量递增试验评估 2 组流感血凝素稳定茎纳米颗粒疫苗
- DOI:
10.1038/s41541-024-00959-0 - 发表时间:
2024-09-17 - 期刊:
- 影响因子:6.500
- 作者:
Joseph P. Casazza;Amelia R. Hofstetter;Pamela J. M. Costner;LaSonji A. Holman;Cynthia S. Hendel;Alicia T. Widge;Richard L. Wu;William R. Whalen;Jennifer Cunningham;Anita Arthur;Xiaolin Wang;Abidemi Ola;Jamie Saunders;Floreliz Mendoza;Laura Novik;Maria C. Burgos Florez;Ana M. Ortega-Villa;Preeti J. Apte;Larisa Strom;Lu Wang;Marjaan Imam;Manjula Basappa;Mursal Naisan;Mike Castro;Jessica F. Trost;Sandeep R. Narpala;Hillary A. Vanderven;Galina V. Yamshchikov;Nina M. Berkowitz;Ingelise J. Gordon;Sarah H. Plummer;Diane L. Wycuff;Sandra Vazquez;Rebecca A. Gillespie;Adrian Creanga;William C. Adams;Kevin Carlton;Jason G. Gall;Adrian B. McDermott;Leonid A. Serebryannyy;Katherine V. Houser;Richard A. Koup;Barney S. Graham;Julie E. Ledgerwood;John R. Mascola;Theodore C. Pierson;Sarah F. Andrews;Masaru Kanekiyo;Lesia K. Dropulic - 通讯作者:
Lesia K. Dropulic
Julie E. Ledgerwood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julie E. Ledgerwood', 18)}}的其他基金
Biodefense and Emerging Infectious Disease Vaccine Studies
生物防御和新发传染病疫苗研究
- 批准号:
10275373 - 财政年份:
- 资助金额:
$ 180.15万 - 项目类别:
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
生物防御和新发传染病单克隆抗体研究
- 批准号:
10497751 - 财政年份:
- 资助金额:
$ 180.15万 - 项目类别:
HIV Preventive Vaccine and Monoclonal Antibody Studies
HIV预防疫苗和单克隆抗体研究
- 批准号:
8946584 - 财政年份:
- 资助金额:
$ 180.15万 - 项目类别:
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
HIV 感染者的疫苗和单克隆抗体研究
- 批准号:
9353052 - 财政年份:
- 资助金额:
$ 180.15万 - 项目类别:
COVID-19 Sample Collection and Vaccine Studies
COVID-19 样本采集和疫苗研究
- 批准号:
10497765 - 财政年份:
- 资助金额:
$ 180.15万 - 项目类别:
相似海外基金
Optimizing blood biopsy in cancers with low mutation burden and high structural complexity
优化突变负荷低、结构复杂性高的癌症的血液活检
- 批准号:
10789700 - 财政年份:2023
- 资助金额:
$ 180.15万 - 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
- 批准号:
576550-2022 - 财政年份:2022
- 资助金额:
$ 180.15万 - 项目类别:
Idea to Innovation
Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
利用血液和其他体液中的 Exoxomal-microRNA 对横纹肌样瘤进行液体活检
- 批准号:
21K07778 - 财政年份:2021
- 资助金额:
$ 180.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10634540 - 财政年份:2021
- 资助金额:
$ 180.15万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10421266 - 财政年份:2021
- 资助金额:
$ 180.15万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10844821 - 财政年份:2021
- 资助金额:
$ 180.15万 - 项目类别:
Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
- 批准号:
21H03021 - 财政年份:2021
- 资助金额:
$ 180.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Monitoring of residual and recurrence of cervical cancer after radiotherapy using blood liquid biopsy.
使用血液活检监测放疗后宫颈癌的残留和复发。
- 批准号:
20K08106 - 财政年份:2020
- 资助金额:
$ 180.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a Novel Liquid Biopsy Technique for Colorectal Cancer Using MicroRNA Editing in Blood
利用血液中的 MicroRNA 编辑建立结直肠癌新型液体活检技术
- 批准号:
20K22848 - 财政年份:2020
- 资助金额:
$ 180.15万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Prediction of colorectal cancer using liquid biopsy of the blood in surgically resected specimen
利用手术切除标本中血液的液体活检预测结直肠癌
- 批准号:
19K09127 - 财政年份:2019
- 资助金额:
$ 180.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




